[HTML][HTML] Open-label randomised phase III trial of vinflunine versus an alkylating agent in patients with heavily pretreated metastatic breast cancer
J Cortes, J Perez-Garcia, C Levy, PG Pardo… - Annals of …, 2018 - Elsevier
Background There is no standard treatment after progression on second-line chemotherapy
for metastatic breast cancer (MBC). We compared vinflunine with physician's choice of …
for metastatic breast cancer (MBC). We compared vinflunine with physician's choice of …
[HTML][HTML] Open-label randomised phase III trial of vinflunine versus an alkylating agent in patients with heavily pretreated metastatic breast cancer
J Cortes, J Perez-Garcia, C Levy, PG Pardo… - Annals of …, 2018 - annalsofoncology.org
Background There is no standard treatment after progression on second-line chemotherapy
for metastatic breast cancer (MBC). We compared vinflunine with physician's choice of …
for metastatic breast cancer (MBC). We compared vinflunine with physician's choice of …
[引用][C] Open-label randomised phase III trial of vinflunine versus an alkylating agent in patients with heavily pretreated metastatic breast cancer
J Cortes, N Martínez-Jañez, E Holgado, PP Gómez… - Annals of …, 2018 - elibrary.ru
This work was supported by Pierre Fabre Médicament, which funded the trial as well as
medical writing support provided by Jennifer Kelly (Medi-Kelsey Ltd, Ashbourne, UK). No …
medical writing support provided by Jennifer Kelly (Medi-Kelsey Ltd, Ashbourne, UK). No …
Open-label randomised phase III trial of vinflunine versus an alkylating agent in patients with heavily pretreated metastatic breast cancer.
J Cortes, J Perez-Garcia, C Levy… - Annals of Oncology …, 2018 - europepmc.org
Background: There is no standard treatment after progression on second-line chemotherapy
for metastatic breast cancer (MBC). We compared vinflunine with physician's choice of …
for metastatic breast cancer (MBC). We compared vinflunine with physician's choice of …
[引用][C] Open-label randomised phase III trial of vinflunine versus an alkylating agent in patients with heavily pretreated metastatic breast cancer
J Cortes, J Perez-Garcia, C Levy… - Annals of …, 2018 - portalcientifico.universidadeuropea …
Background: There is no standard treatment after progression on second-line chemotherapy
for metastatic breast cancer (MBC). We compared vinflunine with physician's choice of …
for metastatic breast cancer (MBC). We compared vinflunine with physician's choice of …
Open-label randomised phase III trial of vinflunine versus an alkylating agent in patients with heavily pretreated metastatic breast cancer
J Cortes, J Perez-Garcia, C Levy… - Annals of oncology …, 2018 - pubmed.ncbi.nlm.nih.gov
Background There is no standard treatment after progression on second-line chemotherapy
for metastatic breast cancer (MBC). We compared vinflunine with physician's choice of …
for metastatic breast cancer (MBC). We compared vinflunine with physician's choice of …
[引用][C] Open-label randomised phase III trial of vinflunine versus an alkylating agent in patients with heavily pretreated metastatic breast cancer
J Cortes, J Perez-Garcia, C Levy… - Annals of …, 2018 - portalcientifico.universidadeuropea …
Background: There is no standard treatment after progression on second-line chemotherapy
for metastatic breast cancer (MBC). We compared vinflunine with physician's choice of …
for metastatic breast cancer (MBC). We compared vinflunine with physician's choice of …